New IQ Case Studies Highlight High Impact Initiatives
February 27, 2019
To provide greater insight into initiatives by IQ working groups, the IQ Consortium has developed a series of case studies about high-impact initiatives that have generated important knowledge and are expected to continue to have significant impacts. These case studies describe challenges identified by IQ working groups and the approach that working groups took to address these challenges, along with results and impact of their work.
The first set of case studies published on our Impact include:
-
Inspiring Sustainable Drug Manufacturing with a Smart Goal Metric
-
Advancing Global Collaboration in Pediatric Formulation Development
-
Assessing the Value of Nonclinical Testing to Enable Safe Entry to First in Human Clinical Trials
With time, IQ will create and post additional case studies. Our goal is to provide diverse perspective on the range of initiatives underway across the Consortium, and how IQ is contributing to positive transformations the pharmaceutical and biotechnology landscapes.